M. H. Carnegie & Co.
M.H. Carnegie & Co. is an Australian boutique private equity and alternative asset manager that co-invests its own capital alongside investor capital, targeting Australian alternative asset opportunities under an alignment-of-interests fee structure.
- Company typePrivate
- Founded2010
- HeadquartersPaddington, Australia
- Headcount1–10
- GTM typeB2B
- OfferingServices
What M. H. Carnegie & Co. does
M.H. Carnegie & Co. is an Australian boutique private equity and alternative asset investment manager established in 2010 by founder Mark Carnegie. The firm operates a co-investment model in which its own capital is deployed alongside investor capital, with performance overrides collected only after investors receive an adequate base return—a structure explicitly designed to align manager and investor economic interests. The firm holds Australian Financial Services Licence (AFSL) number 411216 and is headquartered in Moore Park, Sydney.
The firm serves Australian-based investors seeking alternative asset exposure, positioning asset allocation decisions as the primary driver of portfolio returns and its own investment evaluation work as derivative of those allocation choices. M.H. Carnegie maintains dedicated philanthropic and internship enquiry channels alongside core investment activity, suggesting an institutional, relationship-driven client interface rather than a mass-distribution go-to-market. The firm does not operate a technology product or platform; its output is investment selection and portfolio construction across alternative asset categories.
Available evidence shows the firm participating as an existing investor in Cardiac Dimensions' $53 million Series E round in March 2025, alongside Ally Bridge Group, Hostplus, Horizon 3 Healthcare, Lumira Ventures, and Claret Capital Partners. No AUM figures, vehicle sizes, fund names, fee schedules, or investor roster are disclosed in available sources, limiting visibility into the firm's scale and client base.
M. H. Carnegie & Co. firmographics
Firmographics- Name
- M. H. Carnegie & Co.
- Legal name
- M.H. Carnegie & Co. Pty Ltd
- Website
- https://mhcarnegie.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- M.H. Carnegie & Co. is an Australian boutique private equity and alternative asset manager that co-invests its own capital alongside investor capital, targeting Australian alternative asset opportunities under an alignment-of-interests fee structure.
- Ownership category
- akta.pro rank
M. H. Carnegie & Co. industry classification
Industry- Product category
- Alternative Asset Management
- NAICS
- Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where M. H. Carnegie & Co. is headquartered
LocationHeadquarters
- HQ city
- Paddington
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
M. H. Carnegie & Co. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others
M. H. Carnegie & Co. product offering
Product offeringCore offering
M.H. Carnegie & Co. is an Australian-based alternative asset investment firm that deploys capital into and alongside portfolio companies across multiple sectors, including healthcare technology. The firm positions itself as a partner to investors, emphasizing co-investment alignment where its own capital is invested alongside client capital and override fees are only earned after investors receive an adequate base return.
Product overview
M.H. Carnegie & Co. is an Australian-based alternative asset investment firm that manages investments across various sectors, including healthcare technology. The firm operates as a partnership with investors, emphasizing co-investment opportunities and alignment of economic interests. The company does not appear to offer a unified technology product or platform; rather, it functions as an investment management entity that deploys capital into portfolio companies such as Cardiac Dimensions (a medical device company developing the Carillon Mitral Contour System). No specific named investment products, funds, or managed offerings are enumerated in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Alternative Asset Co-Investment Mandate
Companies that use M. H. Carnegie & Co.
Customer profileIdeal customer profiles1 record
M. H. Carnegie & Co. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
M. H. Carnegie & Co. partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
M. H. Carnegie & Co. competitors and assessment
Company assessmentBroad incumbents
- KKR: Global private equity and alternative asset management firm. Comparable as a broad incumbent in alternatives serving institutional LPs, though vastly larger and more diversified than M.H. Carnegie.
- The Carlyle Group: Global private equity and alternative asset manager. Comparable as a broad incumbent offering alternative asset strategies that overlap with M.H. Carnegie's mandate, though at significantly greater scale and with multi-region capabilities.
Direct peers
- CPE Capital (formerly Catalyst Private Equity): Australian private equity firm investing across mid-market deals. Comparable as an Australia-based PE manager offering direct investment vehicles to LPs.
- Next Capital: Australian lower-mid-market private equity manager. Comparable in serving Australian institutional investors with direct PE investments.
- Allegro Funds: Australian mid-market private equity manager. Directly comparable in target geography (Australia), business model (direct alternative investments for institutional LPs), and team scale.
- Crescent Capital Partners: Australian mid-market private equity manager. Directly comparable to M.H. Carnegie as an Australia-based alternative asset manager serving institutional investors with sector-focused direct investments.
- Adamantem Capital: Australian private equity firm investing in consumer and industrial businesses. Comparable as an Australia-based PE manager with direct alternative investments for institutional capital.
- Quadrant Private Equity: Leading Australian mid-market private equity firm. Comparable to M.H. Carnegie in being an Australia-based PE/alternative asset manager executing direct investments alongside co-investors.
- Anchorage Capital Partners: Australian private equity firm focused on mid-market transactions. Directly comparable in geography, scale, and focus on direct alternative investments.
- Pemba Capital Partners: Australian private equity specialist in mid-market buyouts. Comparable to M.H. Carnegie as a domestic alternative asset manager executing direct sector investments.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
M. H. Carnegie & Co. social profiles
Digital presenceM. H. Carnegie & Co. compliance and trust
Trust signalCompliance1 record
M. H. Carnegie & Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
M. H. Carnegie & Co. leadership team
Management profileNumber of profiles
Profiles2 records
M. H. Carnegie & Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
M. H. Carnegie & Co. M&A and investment
M&A and investmentM&A
Investments11 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about M. H. Carnegie & Co.
What does M. H. Carnegie & Co. do?
M.H. Carnegie & Co. is an Australian-based alternative asset investment firm that deploys capital into and alongside portfolio companies across multiple sectors, including healthcare technology. The firm positions itself as a partner to investors, emphasizing co-investment alignment where its own capital is invested alongside client capital and override fees are only earned after investors receive an adequate base return.
Is M. H. Carnegie & Co. a public or private company?
M. H. Carnegie & Co. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was M. H. Carnegie & Co. founded?
M. H. Carnegie & Co. was founded in 2010. It employs 1 to 10 people.
Where is M. H. Carnegie & Co. based?
M. H. Carnegie & Co. is headquartered in Paddington, Australia, in the Oceania region.
Who are M. H. Carnegie & Co.'s main competitors?
Broad incumbents on record are KKR and The Carlyle Group. Direct peers are CPE Capital (formerly Catalyst Private Equity), Next Capital, Allegro Funds, Crescent Capital Partners, Adamantem Capital, Quadrant Private Equity, Anchorage Capital Partners and Pemba Capital Partners.
Does M. H. Carnegie & Co. have an API?
No public API is recorded for M. H. Carnegie & Co..
What industry is M. H. Carnegie & Co. in?
M. H. Carnegie & Co.'s product category is Alternative Asset Management. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.